Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Advances of cancer therapy by nanotechnology.

Literature DB >> 19688065

Advances of cancer therapy by nanotechnology.

Xu Wang¹, Yiqing Wang, Zhuo Georgia Chen, Dong M Shin.

Abstract

Recent developments in nanotechnology offer researchers opportunities to significantly transform cancer therapeutics. This technology has enabled the manipulation of the biological and physicochemical properties of nanomaterials to facilitate more efficient drug targeting and delivery. Clinical investigations suggest that therapeutic nanoparticles can enhance efficacy and reduced side effects compared with conventional cancer therapeutic drugs. Encouraged by rapid and promising progress in cancer nanotechnology, researchers continue to develop novel and efficacious nanoparticles for drug delivery. The use of therapeutic nanoparticles as unique drug delivery systems will be a significant addition to current cancer therapeutics.

Entities: Disease

Keywords: Cancer therapy; Drug delivery; Nanoparticels

Year: 2009 PMID： 19688065 PMCID： PMC2699095 DOI： 10.4143/crt.2009.41.1.1

Source DB: PubMed Journal: Cancer Res Treat ISSN： 1598-2998 Impact factor: 4.679

134 in total

1. In vivo studies of fullerene-based materials using endohedral metallofullerene radiotracers.

Authors: D W Cagle; S J Kennel; S Mirzadeh; J M Alford; L J Wilson
Journal: Proc Natl Acad Sci U S A Date: 1999-04-27 Impact factor: 11.205

2. PIONEER: a phase III randomized trial of paclitaxel poliglumex versus paclitaxel in chemotherapy-naive women with advanced-stage non-small-cell lung cancer and performance status of 2.

Authors: Kathy S Albain; Chandra P Belani; Philip Bonomi; Kenneth J O'Byrne; Joan H Schiller; Mark Socinski
Journal: Clin Lung Cancer Date: 2006-05 Impact factor: 4.785

3. Phase I study of CT-2103, a polymer-conjugated paclitaxel, and carboplatin in patients with advanced solid tumors.

Authors: John Nemunaitis; Casey Cunningham; Neil Senzer; Megan Gray; Fred Oldham; John Pippen; Robert Mennel; Amy Eisenfeld
Journal: Cancer Invest Date: 2005 Impact factor: 2.176

4. Liposomal drug delivery.

Authors: S Dean Allison
Journal: J Infus Nurs Date: 2007 Mar-Apr

Review 5. Magnetic nanoparticles in MR imaging and drug delivery.

Authors: Conroy Sun; Jerry S H Lee; Miqin Zhang
Journal: Adv Drug Deliv Rev Date: 2008-04-10 Impact factor: 15.470

6. Phase I clinical and pharmacokinetic study of PNU166945, a novel water-soluble polymer-conjugated prodrug of paclitaxel.

Authors: J M Meerum Terwogt; W W ten Bokkel Huinink; J H Schellens; M Schot; I A Mandjes; M G Zurlo; M Rocchetti; H Rosing; F J Koopman; J H Beijnen
Journal: Anticancer Drugs Date: 2001-04 Impact factor: 2.248

7. Application of nanotechnology in cancer therapy and imaging.

Authors: Xu Wang; Lily Yang; Zhuo Georgia Chen; Dong M Shin
Journal: CA Cancer J Clin Date: 2008-01-28 Impact factor: 508.702

8. A phase II study of liposomal lurtotecan (OSI-211) in patients with topotecan resistant ovarian cancer.

Authors: Michael V Seiden; Franco Muggia; Allan Astrow; Ursula Matulonis; Susanna Campos; Maria Roche; Julia Sivret; Jason Rusk; Emma Barrett
Journal: Gynecol Oncol Date: 2004-04 Impact factor: 5.482

Review 9. How can we best use structural information on P-glycoprotein to design inhibitors?

Authors: Christopher A McDevitt; Richard Callaghan
Journal: Pharmacol Ther Date: 2006-11-18 Impact factor: 12.310

10. Phase II study of SPI-77 (sterically stabilised liposomal cisplatin) in advanced non-small-cell lung cancer.

Authors: S C White; P Lorigan; G P Margison; J M Margison; F Martin; N Thatcher; H Anderson; M Ranson
Journal: Br J Cancer Date: 2006-09-12 Impact factor: 7.640

35 in total

Review 1. Theranostic applications of nanomaterials in cancer: drug delivery, image-guided therapy, and multifunctional platforms.

Authors: Alicia Fernandez-Fernandez; Romila Manchanda; Anthony J McGoron
Journal: Appl Biochem Biotechnol Date: 2011-09-27 Impact factor: 2.926

Review 2. Nanoparticle delivery systems for cancer therapy: advances in clinical and preclinical research.

Authors: Susana Patricia Egusquiaguirre; Manuela Igartua; Rosa María Hernández; José Luis Pedraz
Journal: Clin Transl Oncol Date: 2012-02 Impact factor: 3.405

3. Biodegradable polymeric nanoparticles containing gold nanoparticles and Paclitaxel for cancer imaging and drug delivery using photoacoustic methods.

Authors: Yanjie Wang; Eric M Strohm; Yang Sun; Zhaoxia Wang; Yuanyi Zheng; Zhigang Wang; Michael C Kolios
Journal: Biomed Opt Express Date: 2016-09-16 Impact factor: 3.732

Review 4. Basics to advances in nanotherapy of colorectal cancer.

Authors: Ankita Tiwari; Shivani Saraf; Ankit Jain; Pritish K Panda; Amit Verma; Sanjay K Jain
Journal: Drug Deliv Transl Res Date: 2020-04 Impact factor: 4.617

Review 5. Informatics and standards for nanomedicine technology.

Authors: Dennis G Thomas; Fred Klaessig; Stacey L Harper; Martin Fritts; Mark D Hoover; Sharon Gaheen; Todd H Stokes; Rebecca Reznik-Zellen; Elaine T Freund; Juli D Klemm; David S Paik; Nathan A Baker
Journal: Wiley Interdiscip Rev Nanomed Nanobiotechnol Date: 2011-06-30